Previous close | 0.0100 |
Open | 0.0200 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 30.00 |
Expiry date | 2024-06-21 |
Day's range | 0.0100 - 0.0200 |
Contract range | N/A |
Volume | |
Open interest | 2.08k |
PRINCETON, N.J., May 23, 2024--Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
A judge in Hawaii has reportedly ordered Bristol Myers Squibb & Co (NYSE:BMY) and Sanofi SA (NASDAQ:SNY) to pay the state over $916 million for failing to warn non-white patients about health risks associated with their blood thinner Plavix. This decision marks an increase from an earlier $834 million judgment. Judge James Ashford of Hawaii’s First Circuit Court’s ruling follows a non-jury trial held last fall and represents the second trial in this case. The state’s Supreme Court had previously
The FDA assigns a new target action date of Dec 29, 2024, to Bristol Myers (BMY) BLA for subcutaneous nivolumab (nivolumab and hyaluronidase).